Nascent Biotech, Inc.
NBIO
$0.00
$0.00-86.96%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -87.26% | -40.36% | -37.86% | 10,468.42% | -94.48% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | 934.48% | -55.04% | -44.24% | -16.18% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -58.81% | -13.91% | -38.50% | 1,221.55% | -69.06% |
|
|
|||||
| Total Current Assets | -58.81% | -13.91% | -38.50% | 1,221.55% | -69.06% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -58.81% | -13.91% | -38.50% | 1,221.55% | -69.06% |
|
|
|||||
| Total Accounts Payable | -0.50% | 41.86% | -5.16% | -20.83% | 29.35% |
| Total Accrued Expenses | -- | -- | -95.93% | -- | -- |
| Short-term Debt | -51.84% | -2.00% | -59.02% | 10.11% | -28.90% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -42.44% | -52.86% |
| Total Other Current Liabilities | -- | -- | -- | -42.44% | -52.86% |
| Total Current Liabilities | -8.27% | 32.39% | -41.77% | -14.98% | -20.44% |
|
|
|||||
| Total Current Liabilities | -8.27% | 32.39% | -41.77% | -14.98% | -20.44% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -51.84% | -2.00% | -59.02% | 10.11% | -28.90% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -8.27% | 32.39% | -41.77% | -14.98% | -20.44% |
|
|
|||||
| Common Stock & APIC | 0.50% | 0.95% | 1.03% | 12.03% | 3.35% |
| Retained Earnings | -1.56% | -2.16% | -0.87% | -6.22% | -2.50% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -100.43% | -944.41% | 575.00% | 99.45% | 10.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -100.43% | -944.41% | 575.00% | 99.45% | 10.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -100.43% | -944.41% | 575.00% | 99.45% | 10.89% |
|
|
|||||